Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma

Clinical trial NCT03799744 · UNKNOWN

Trial details

NCT number: NCT03799744
Sponsor: Institut Català d'Oncologia
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Neoplasms Carcinoma, Squamous Cell of Head and Neck Metastasis Recurrence

Start date: 2019-03-20
Primary completion: 2023-01-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.